Survival trend in metastatic prostate cancer two decades of real-world data on overall survival from Germany
Real-world data confirm meaningful survival improvements in metastatic prostate cancer over two decades, validating the translation of clinical trial efficacy into routine practice. However, the pronounced age-related disparity suggests potential undertreatment of elderly patients and highlights the need for age-adapted treatment strategies.
Authors
- Viktoria Menzel (ORCID: https://orcid.org/0009-0002-3153-6775)
- Marcus Sondermann (ORCID: https://orcid.org/0000-0002-4629-0707)
- Katharina Böehm (ORCID: https://orcid.org/0000-0002-0527-1809)
- Christopher Hirtsiefer
- Klaus Kraywinkel
- Nina Buttmann-Schweiger
- Paul Wilhelm Flemming
- Christian Thomas
- Anton Stehr
Institutions
- University of British Columbia (CA)
- German Cancer Society (DE)
- University Hospital Carl Gustav Carus (DE)
- Klinik und Poliklinik für Psychotherapie und Psychosomatik (DE)
Publication Details
- Journal
- Prostate Cancer and Prostatic Diseases
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1038/s41391-026-01092-w
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 36.44
Funders
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- Robert Koch Institut